Advertisement
Free access | 10.1172/JCI109817
Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Binnengasthuis, University of Amsterdam, Amsterdam, Netherlands
Laboratory for Experimental and Clinical Immunology, and Pediatric Clinic, Binnengasthuis, University of Amsterdam, Amsterdam, Netherlands
Medizinisch-chemisches Institut der Universität Bern, Bern, Switzerland
Find articles by Roos, D. in: JCI | PubMed | Google Scholar
Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Binnengasthuis, University of Amsterdam, Amsterdam, Netherlands
Laboratory for Experimental and Clinical Immunology, and Pediatric Clinic, Binnengasthuis, University of Amsterdam, Amsterdam, Netherlands
Medizinisch-chemisches Institut der Universität Bern, Bern, Switzerland
Find articles by Weening, R. in: JCI | PubMed | Google Scholar
Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Binnengasthuis, University of Amsterdam, Amsterdam, Netherlands
Laboratory for Experimental and Clinical Immunology, and Pediatric Clinic, Binnengasthuis, University of Amsterdam, Amsterdam, Netherlands
Medizinisch-chemisches Institut der Universität Bern, Bern, Switzerland
Find articles by Wyss, S. in: JCI | PubMed | Google Scholar
Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Binnengasthuis, University of Amsterdam, Amsterdam, Netherlands
Laboratory for Experimental and Clinical Immunology, and Pediatric Clinic, Binnengasthuis, University of Amsterdam, Amsterdam, Netherlands
Medizinisch-chemisches Institut der Universität Bern, Bern, Switzerland
Find articles by Aebi, H. in: JCI | PubMed | Google Scholar
Published June 1, 1980 - More info
To investigate the importance of catalase as a protecting enzyme against oxidative damage in phagocytic leukocytes, we have tested the functional capacity of neutrophils from two individuals homozygous for Swiss-type acatalasemia and from two individuals heterozygous for this deficiency. In the former cells, 25-30% of residual activity of catalase was present. In the latter cells, the values were close to normal.
Chemotaxis towards casein, release of lysosomal enzymes and hydrogen peroxide during phagocytosis of zymosan, and intracellular killing of Staphylococcus aureus were normal in all cells tested. Inhibition of heme enzymes with azide (2 mM) enhanced the respiration and hexose monophosphate shunt activity of normal, but not of homozygous acatalasemic, neutrophils. This indicates that the enhancement in normal cells is, at least in part, due to catalase inhibition.
After 15 min preincubation with an H2O2-generating system (glucose plus glucose oxidase), the respiratory response to zymosan phagocytosis was strongly depressed in the homozygous acatalasemic and in normal, azide-treated neutrophils, but not in normal, untreated cells. Under these conditions, the release of lysosomal enzymes was depressed and that of lactate dehydrogenase enhanced, in catalase-deficient and in catalase-inhibited, but not in normal, neutrophils. During prolonged incubation with the H2O2-generating system (30-60 min), the reduction level of intracellular glutathione remained high and the hexose monophosphate shunt continued to operate normally in all cells tested. Thus, although the function of neutrophils without catalase activity was depressed by extracellular hydrogen peroxide, the H2O2 degradation via the glutathione redox system remained operative.
The results indicate that the glutathione redox system by itself efficiently protects phagocytosing neutrophils against their own oxidative products. During heavy external oxidative stress, however, both catalase and the glutathione redox system are needed for adequate protection.